Realize Medical Receives FDA Clearance For Virtual Reality Surgical Planning Software

OTTAWA, CANADA, January 19, 2023—Healthcare software start-up, Realize Medical, announced today that its virtual reality (VR) software for surgical planning, Elucis (ee-loo-sis), has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

“As one of the youngest companies in the mixed reality space, FDA clearance is a significant milestone – allowing us to transform our advanced and leading VR software into real benefits for physicians and their patients.”

Elucis enables medical professionals to quickly create, understand, and share complex patient anatomy from CTs and MRIs in an immersive 3D environment. The one-of-a-kind virtual collaboration tool lets users connect with other users in a fully functional virtual reality environment from within VR or through desktop PCs. The platform can be used to improve 3D pre-operative planning and patient consultations.

“Virtual planning with Elucis allows me to conceptualize innovative procedures with the end product of successful cases, development of new devices, and improved education for patients and families,” said Jenny Zablah MD, Congenital Interventional Cardiologist, Colorado.

Current and planned use cases for Elucis are expected to align to the needs of surgeons across all disciplines.

“We’re often told that Elucis represents the most advanced offering in the mixed reality space. But with powerful image processing, modeling, and collaboration tools, it’s also a comprehensive and complete platform for serving the full suite of growing 3D needs in medicine. With FDA clearance, we’re truly excited to enable an expanding era of procedure planning and collaboration.” – Justin Sutherland, CEO

About Realize Medical

Realize Medical is the creator of Elucis, all-in-one virtual reality-based medical modeling, surgical planning, and collaboration platform. The U.S. Food and Drug Administration cleared the software for use in 2023. Realize Medical is headquartered in Ottawa, Ontario.

Follow our progress at https://www.realizemed.com and connect with us on LinkedIn

Media and Investor Contact:
Sonya Deveau
Vice President Sales and Operations
Realize Medical
sonya@realizemed.com

About Peter Coffaro 510 Articles
Peter Coffaro is a growth-driven and strategic executive with over 25 years of progressive management success in the medical device industry. With a proven track record and recognized expertise, Peter has established himself as one of the top influencers in medical sales, as acknowledged by prestigious publications such as the World Journal of Orthopedics, Exponential Healthtech, and MedReps.com. Throughout his career, Peter has accumulated 10 years of combined sales management experience, excelling in various roles including Director, General Manager, Distributor, and Vice President. He has worked for industry-leading orthopedic companies such as Zimmer, DePuy, and Stryker, solidifying his deep knowledge and network within the field. Peter’s passion for innovation and emerging technologies led him to found OrthoFeed, an award-winning blog covering digital orthopedic news and emerging medical technologies. Through this platform, he stays at the forefront of the industry and contributes to the dissemination of valuable insights. Peter is a three-time Hall of Fame award winner at Johnson and Johnson, demonstrating his exceptional contributions and impact on the organization. His expertise extends to areas such as organizational development, business development, sales management, digital marketing, and professional education. Peter earned a B.S. degree in Biology and Chemistry from Northern Illinois University, further complementing his comprehensive understanding of the medical field. With his wealth of experience, strategic mindset, and dedication to advancing healthcare, Peter Coffaro is a valuable asset and leader in the medical device industry.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.